PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group (original) (raw)
Gilliland DG, Griffin JD . The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532–1542. ArticleCASPubMed Google Scholar
Meshinchi S, Stirewalt DL, Alonzo TA, Zhang Q, Sweetser DA, Woods WG et al. Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia. Blood 2003; 102: 1474–1479. ArticleCASPubMed Google Scholar
Radich JP, Kopecky KJ, Willman CL, Weick J, Head D, Appelbaum F et al. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood 1990; 76: 801–807. CASPubMed Google Scholar
Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911–1918. CASPubMed Google Scholar
Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE . Crystal structure of the tyrosine phosphatase SHP-2. Cell 1998; 92: 441–450. ArticleCASPubMed Google Scholar
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29: 465–468. ArticleCASPubMed Google Scholar
Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002; 70: 1555–1563. ArticleCASPubMedPubMed Central Google Scholar
Arico M, Biondi A, Pui CH . Juvenile myelomonocytic leukemia. Blood 1997; 90: 479–488. CASPubMed Google Scholar
Emanuel PD, Shannon KM, Castleberry RP . Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy. Mol Med Today 1996; 2: 468–475. ArticleCASPubMed Google Scholar
Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 1997; 89: 3534–3543. CASPubMed Google Scholar
Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34: 148–150. ArticleCASPubMed Google Scholar
Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 2004; 103: 2325–2331. ArticleCASPubMed Google Scholar
Sievers EL, Lange BJ, Sondel PM, Krailo MD, Gan J, Liu-Mares W et al. Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 914–919. ArticleCASPubMed Google Scholar
Sievers EL, Lange BJ, Sondel PM, Krailo MD, Gan J, Tjoa T et al. Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia. Cancer J Sci Am 2000; 6 (Suppl 1): S39–S44. PubMed Google Scholar
Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001; 97: 89–94. ArticleCASPubMed Google Scholar
Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481. Article Google Scholar
Greenwood M . Reports on Public Health and Medical Subjects, Vol. 33. London: His Majesty's Stationery Office, 1926. Google Scholar
Peto R, Peto J . Asymptotically efficient rank in variant test procedures. J R Stat Soc A 1972; 135: 185–206. Article Google Scholar
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333. CASPubMed Google Scholar
Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J et al. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci USA. 2004; 101: 597–602. ArticleCASPubMed Google Scholar
Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H et al. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 2004; 113: 528–538. ArticleCASPubMedPubMed Central Google Scholar
Jung A, Bechthold S, Pfluger T, Renner C, Ehrt O . Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 2003; 25: 330–332. ArticlePubMed Google Scholar
Agras PI, Baskin E, Sakallioglu AE, Arda IS, Ayter S, Oguzkan S et al. Neurofibromatosis – Noonan's syndrome with associated rhabdomyosarcoma of the urinary bladder in an infant: case report. J Child Neurol 2003; 18: 68–72. ArticlePubMed Google Scholar
Bisogno G, Murgia A, Mammi I, Strafella MS, Carli M . Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome. J Pediatr Hematol Oncol 1999; 21: 424–427. ArticleCASPubMed Google Scholar
Johannes JM, Garcia ER, De Vaan GA, Weening RS . Noonan's syndrome in association with acute leukemia. Pediatr Hematol Oncol 1995; 12: 571–575. ArticleCASPubMed Google Scholar
Klopfenstein KJ, Sommer A, Ruymann FB . Neurofibromatosis – Noonan syndrome and acute lymphoblastic leukemia: a report of two cases. J Pediatr Hematol Oncol 1999; 21: 158–160. ArticleCASPubMed Google Scholar
Bader-Meunier B, Tchernia G, Miélot F, Fontaine JL, Thomas C, Lyonnet S et al. Occurrence of myeloproliferative disorder in patients with the Noonan syndrome. J Pediatr 1997; 130: 885–889. ArticleCASPubMed Google Scholar
Bertola DR, Carneiro JD, D'Amico EA, Kim CA, Albano LM, Sugayama SM et al. Hematological findings in Noonan syndrome. Rev Hosp Clin Fac Med Sao Paulo 2003; 58: 5–8. ArticlePubMed Google Scholar
Massarano AA, Wood A, Tait RC, Stevens R, Super M . Noonan syndrome: coagulation and clinical aspects. Acta Paediatr 1996; 85: 1181–1185. ArticleCASPubMed Google Scholar
Witt DR, McGillivray BC, Allanson JE, Hughes HE, Hathaway WE, Zipursky A et al. Bleeding diathesis in Noonan syndrome: a common association. Am J Med Genet 1988; 31: 305–317. ArticleCASPubMed Google Scholar
Fragale A, Tartaglia M, Wu J, Gelb BD . Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum Mutat 2004; 23: 267–277. ArticleCASPubMed Google Scholar